Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
RESEARCH TOOLSreports
Cipher Pharmaceuticals (CPH) Stock Price & Analysis
38 Followers
CPH Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$3.11 - C$9.98
Previous CloseC$8.81
Volume3.90K
Average Volume (3M)46.90K
Market Cap
C$211.64M
Enterprise ValueC$157.56M
Total Cash (Recent Filing)$39.83M
Total Debt (Recent Filing)$353.00K
Price to Earnings (P/E)7.9
Beta-0.18
Next Earnings
May 09, 2024EPS Estimate
C$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.11
Shares Outstanding23,989,953
10 Day Avg. Volume29,855
30 Day Avg. Volume46,902
Standard Deviation0.16
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.39
Price to Sales (P/S)9.68
Price to Cash Flow (P/CF)15.60
P/FCF Ratio16.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.45
Enterprise Value/Gross Profit9.22
Enterprise Value/Ebitda9.47
Forecast
1Y Price Target
C$7.99Price Target Upside-6.03% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cipher Pharmaceuticals News
PremiumCompany Announcements
Cipher Pharmaceuticals Posts Steady Growth in 2023
Options Prices
Currently, No data available
---
Ownership Overview
51.56% Insiders
0.95% Mutual Funds
0.84% Other Institutional Investors
46.65% Public Companies and
Individual Investors
CPH FAQ
What was Cipher Pharmaceuticals’s price range in the past 12 months?
Cipher Pharmaceuticals lowest stock price was C$3.11 and its highest was C$9.98 in the past 12 months.
What is Cipher Pharmaceuticals’s market cap?
Currently, no data Available
When is Cipher Pharmaceuticals’s upcoming earnings report date?
Cipher Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 12 days.
How were Cipher Pharmaceuticals’s earnings last quarter?
Cipher Pharmaceuticals released its earnings results on Mar 14, 2024. The company reported C$0.411 earnings per share for the quarter, beating the consensus estimate of C$0.13 by C$0.281.
Is Cipher Pharmaceuticals overvalued?
According to Wall Street analysts Cipher Pharmaceuticals’s price is currently Overvalued.
Does Cipher Pharmaceuticals pay dividends?
Cipher Pharmaceuticals does not currently pay dividends.
What is Cipher Pharmaceuticals’s EPS estimate?
Cipher Pharmaceuticals’s EPS estimate is C$0.14.
How many shares outstanding does Cipher Pharmaceuticals have?
Cipher Pharmaceuticals has 24,022,339 shares outstanding.
What happened to Cipher Pharmaceuticals’s price movement after its last earnings report?
Cipher Pharmaceuticals reported an EPS of C$0.411 in its last earnings report, beating expectations of C$0.13. Following the earnings report the stock price went up 13.604%.
Which hedge fund is a major shareholder of Cipher Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:CPH
---
Cipher Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$7.99 (-6.03% Downside)
C$7.99 (-6.03% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
155.51%
12-Months-Change
Fundamentals
Return on Equity
28.19%
Trailing 12-Months
Asset Growth
16.61%
Trailing 12-Months
Company Description
Cipher Pharmaceuticals
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.
---
CPH Earnings Call
Q4 2024
0:00 / 0:00
---
CPH Stock 12 Months Forecast
Average Price Target
C$7.99
▼(-6.03% Downside)
Technical Analysis
Best Analysts Covering CPH
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+57.45%
reiterated a buy rating last month
Copying Justin Keywood's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +57.45% per trade.
---